Baird Financial Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,665
Closed -$267K 1736
2022
Q4
$267K Sell
13,665
-258
-2% -$5.03K ﹤0.01% 1498
2022
Q3
$336K Sell
13,923
-133
-0.9% -$4.1K ﹤0.01% 1419
2022
Q2
$442K Sell
14,056
-728
-5% -$26.4K ﹤0.01% 1393
2022
Q1
$650K Buy
14,784
+503
+4% +$21.6K ﹤0.01% 1313
2021
Q4
$621K Sell
14,281
-881
-6% -$34.5K ﹤0.01% 1388
2021
Q3
$474K Buy
+15,162
New +$597K ﹤0.01% 1484
2017
Q4
Sell
-14,356
Closed -$419K 1290
2017
Q3
$419K Buy
+14,356
New +$424K ﹤0.01% 1028
2017
Q2
Sell
-63,126
Closed -$2.18M 1241
2017
Q1
$2.18M Buy
63,126
+750
+1% +$26.8K 0.02% 574
2016
Q4
$2.2M Sell
62,376
-175
-0.3% -$5.91K 0.02% 554
2016
Q3
$2.17M Buy
+62,551
New +$2.19M 0.02% 538

Other funds holding ACH

Baird Financial Group's ACH Position: Q1 2023 in Review

Baird Financial Group sold out of Accendra Health (ACH) in Q1 2023, closing a stake of 13,665 shares — an estimated $267K sold.

Baird Financial Group first reported a position in ACH in Q3 2016 and held it in 10 quarters. The position peaked at $2.2M in Q4 2016. 218 funds tracked by Wall St. Rank hold ACH as of Q1 2023.

  • Baird Financial Group reported no remaining Accendra Health position as of Q1 2023 after selling out during the quarter.
  • Baird Financial Group sold 13,665 Accendra Health shares in Q1 2023, an estimated $267K.
  • Baird Financial Group first reported a position in Accendra Health in Q3 2016 and held it in 10 quarters.
  • Baird Financial Group's Accendra Health position peaked at $2.2M in Q4 2016.
  • 218 funds tracked by Wall St. Rank held Accendra Health as of Q1 2023.

Based on Baird Financial Group's 13F filing for Q1 2023, filed 15 May 2023.